目的:观察晚期糖基化终产物(AGEs)对足细胞整合素连接激酶的影响及可能机制。方法:不同浓度的AGEs干预小鼠足细胞,分别检测足细胞整合素连接激酶(ILK)的表达、足细胞黏附性和足细胞上清血管紧张素Ⅱ的浓度,然后预氯沙坦(100 μmol)预处理足细胞后,观察足细胞ILK和黏附性的变化。结果:AGEs(80 μg/ml)干预足细胞24h可明显上调ILK的表达[(200±22)%vs.100%,P〈0.05],降低足细胞的黏附性[(40±13)%vs.100%,P〈0.05],同时升高细胞上清中血管紧张素Ⅱ的浓度[(11.2±0.8)vs.(7.0±0.7)ps/ml,P〈0.05],而氯沙坦预处理可减轻AGEs介导的ILK的上调[(124±25)%vs.(2004±22)%,P〈0.05],足细胞的黏附性也明显改善[(75±13)%VS.(40±13)%,P〈0.05]。结论:AGEs可能通过激活足细胞内的肾素-血管紧张素系统,上调足细胞ILK的表达,降低足细胞的黏附性。
Objective:To investigate the effects and mechanism of advanced glycation end products (AGEs) on the expression of integrin linked kinase(ILK) in podocytes. Methods :Immortalized mouse podocytes were exposed to different concentrations of AGEs, expression levels of ILK protein were measured by western blot, podocyte adhesion was evaluated by hexosaminidase assay, angiotensin Ⅱ levels were measured by enzyme - linked immunosorbent assay. Then podocytes were pretreated with angiotensin Ⅱ type 2 receptor losartan, the changes of ILK and podocyte adhesion were observed. Results: Treatment with AGEs ( 80 μg/ml) for 24 hours resulted in an incremental rise in ILK expression up to an increase of 100% and a significant, dose -dependent decrease in podocyte adhesion [(40 ± 13)% vs. 100%, P 〈0.05] . AGEs also increased angiotensin I1 levels significantly[(11.2 ±0.8) vs. (7.0 ±0.7) pg/ml,P 〈 0.05]. Pretreatment with losartan significantly prevented the upregulation of ILK [(124±25 ) % vs. (200±22 ) %, P 〈 0.05 ] and improved podocyte adhesion compared with podocytes exposed to AGEs [ (75 ± 13 ) % vs. (40 ± 13) % ,P 〈 0.05]. Conclusion:Our findings indicate that AGEs upregulate ILK expression, which occurres partly through activation of the renin - angiotensin system in podocytes.